Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any annular epidermolytic ichthiosis in which the cause of the disease is a variation in the KRT10 gene.
Features include always present findings: Erythema, Orthokeratosis, Dry, scaly skin (ichthyosis), and Abnormal blistering of the skin and others; and common findings: Erythematous plaque, Scaling skin, and Flexural lichenification. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 9 | Erythematous plaque, Abnormal nail morphology, Erythema |
KRT10 encodes keratin 10 (584 aa). Plays a role in the establishment of the epidermal barrier on plantar skin. Involved in the maintenance of cell layer development and keratin filament bundles in suprabasal cells of the epithelium Highest expression in Skin Sun Exposed Lower leg (24,040 TPM) and Skin Not Sun Exposed Suprapubic (20,397 TPM).
Ichthyosis, annular epidermolytic 1 is associated with mutations in the KRT10 gene on chromosome 17.
The KRT10 protein participates in Keratinocyte of spinosum layer differentiates into keratinocyte of granulosum layer in interfollicular epidermis, Transit-amplifying cell of basal layer differentiates into keratinocyte of spinosum layer in interfollicular epidermis, and Keratinocyte of granulosum layer differentiates into corneocyte of corneum layer in interfollicular epidermis pathways.
KRT10 is classified as a druggable target (Cell Surface category) with score 11.6.
Genetic testing for KRT10 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for ichthyosis, annular epidermolytic 1 has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 3 common features.
No clinical trials have been registered for ichthyosis, annular epidermolytic 1.
2 publications have been identified in PubMed for ichthyosis, annular epidermolytic 1. Research spans Diagnostic / Biomarker (50%) and Case Report / Case Series (50%).
Süßmuth K (2026). [PMID: 41892076](https://pubmed.ncbi.nlm.nih.gov/41892076/). *Dermatopathology (Basel)*. [Diagnostic / Biomarker]
Smits E (2025). [PMID: 40741111](https://pubmed.ncbi.nlm.nih.gov/40741111/). *Clin Case Rep*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 12:13 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Pregnancy and birth |
1 |
Congenital bullous ichthyosiform erythroderma |